Open original FDA record ↗Recall record
- FDA identifier
- Z-1873-2014
- Company in FDA record
- JAS Diagnostics Inc.
- FDA classification date
- Jun 25, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
JAS Diagnostics, Inc. of Miami Lakes, FL is recalling their Glucose Hexokinase reagent due to certain lots not performing according to their specifications.
Source facts
- Action
- JAS Diagnostics, Inc. sent an Important Product Recall Information letter dated April 7, 2014 to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. The customers were instructed to: 1) Screen their inventory for any of the lots listed in the letter and discontinue use immediately. 2) Contact the Customer Service Department at 305-748-2762 or 305-748-2763 to obtain replacement product.
- Initiated
- 2014-04-07
- Root cause
- Mixed-up of materials/components
- Terminated
- 2014-08-21
- Distribution
- Worldwide Distribution - US including Puerto Rico and the states of CA, FL, TX, PA, GA, KY, MI, NY, OK, MN, TN, VA, NC, NV, NJ and WV, and the countries of Barbados, Ghana, Trinidad, Tobago, Canada and Haiti.
- Recall number
- Z-1873-2014
- Recall status
- Terminated
- CDRH record ID
- 127383
- FDA classified
- 2014-06-25
- Recall event number
- 68343